TY - JOUR
T1 - Does pulsed field ablation regress over time? A quantitative temporal analysis of pulmonary vein isolation
AU - Kawamura, Iwanari
AU - Neuzil, Petr
AU - Shivamurthy, Poojita
AU - Petru, Jan
AU - Funasako, Moritoshi
AU - Minami, Kentaro
AU - Kuroki, Kenji
AU - Dukkipati, Srinivas R.
AU - Koruth, Jacob S.
AU - Reddy, Vivek Y.
N1 - Funding Information:
Disclosures: Dr Reddy owns stock in Farapulse and has served as a consultant for Farapulse, Biosense Webster, and Boston Scientific. Dr Reddy also has conflicts with other medical companies unrelated to this manuscript; a full list is provided in Online Supplemental Appendix . Dr Neuzil has received grant support from Farapulse, CardioFocus, Biosense Webster , and Abbott . Dr Dukkipati owns stock in Farapulse and Manual Surgical Sciences, serves as a consultant to CardioFocus, and has received grant support from Biosense Webster . Dr Koruth serves as a consultant to and has received grant support from Farapulse. Dr Koruth also has conflicts with other companies not related to this manuscript (see the Online Supplement ). The rest of the authors report no conflicts of interest.
Funding Information:
Funding sources: The trials were supported by the manufacturer of the pulse field ablation system, Farapulse Inc.
Publisher Copyright:
© 2021 Heart Rhythm Society
PY - 2021/6
Y1 - 2021/6
N2 - Background: The tissue specificity of pulsed field ablation (PFA) makes it an attractive energy source for pulmonary vein (PV) isolation (PVI). However, beyond each PFA lesion's zone of irreversible electroporation and cell death, there may be a surrounding zone of reversible electroporation and cell injury that could potentially normalize with time. Objective: The purpose of this study was to assess whether the level of electrical PVI that is observed acutely after PFA regresses over time. Methods: In a clinical trial, patients with paroxysmal atrial fibrillation underwent PVI using a biphasic PFA waveform delivered through a dedicated, variably deployable multielectrode basket/flower catheter. Detailed voltage maps were created using a multispline diagnostic catheter immediately after PFA and again ∼3 months later in a prospective, protocol-specified reassessment procedure. We analyzed 20 patients who underwent PFA with durable PVI and available maps from both time points. To compare the ablated zones, the left- and right-sided PV antral isolation areas and nonablated posterior wall area were quantified and the distances between left and right PV low-voltage edges were measured. Results: A comparison of voltage maps immediately after PFA and at a median of 84 days (interquartile range 69–90 days) later revealed that there was no significant difference in either the left- and right-sided PV antral isolation areas or nonablated posterior wall area. The distances between low-voltage edges on the posterior wall were also not significantly different between the 2 time points. Conclusion: This study demonstrates that the level of PV antral isolation after PFA with a multielectrode PFA catheter persists without regression.
AB - Background: The tissue specificity of pulsed field ablation (PFA) makes it an attractive energy source for pulmonary vein (PV) isolation (PVI). However, beyond each PFA lesion's zone of irreversible electroporation and cell death, there may be a surrounding zone of reversible electroporation and cell injury that could potentially normalize with time. Objective: The purpose of this study was to assess whether the level of electrical PVI that is observed acutely after PFA regresses over time. Methods: In a clinical trial, patients with paroxysmal atrial fibrillation underwent PVI using a biphasic PFA waveform delivered through a dedicated, variably deployable multielectrode basket/flower catheter. Detailed voltage maps were created using a multispline diagnostic catheter immediately after PFA and again ∼3 months later in a prospective, protocol-specified reassessment procedure. We analyzed 20 patients who underwent PFA with durable PVI and available maps from both time points. To compare the ablated zones, the left- and right-sided PV antral isolation areas and nonablated posterior wall area were quantified and the distances between left and right PV low-voltage edges were measured. Results: A comparison of voltage maps immediately after PFA and at a median of 84 days (interquartile range 69–90 days) later revealed that there was no significant difference in either the left- and right-sided PV antral isolation areas or nonablated posterior wall area. The distances between low-voltage edges on the posterior wall were also not significantly different between the 2 time points. Conclusion: This study demonstrates that the level of PV antral isolation after PFA with a multielectrode PFA catheter persists without regression.
KW - Atrial fibrillation
KW - Electroporation
KW - Level of isolation
KW - Pulmonary vein isolation
KW - Pulsed field ablation
UR - http://www.scopus.com/inward/record.url?scp=85103103811&partnerID=8YFLogxK
U2 - 10.1016/j.hrthm.2021.02.020
DO - 10.1016/j.hrthm.2021.02.020
M3 - Article
C2 - 33647464
AN - SCOPUS:85103103811
SN - 1547-5271
VL - 18
SP - 878
EP - 884
JO - Heart Rhythm
JF - Heart Rhythm
IS - 6
ER -